Calamine with zinc oxide
Brand names: various calamine lotion
Calamine with zinc oxide is a soothing topical preparation, commonly as a lotion or cream, used to relieve itching and mild irritation of the skin.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It acts as a mild astringent and provides a cooling, soothing effect on the skin that helps relieve pruritus, with zinc oxide also offering mild protective properties.
Prescribing in practice
- It provides only symptomatic relief and does not treat the underlying cause of itch, which should be identified and managed.
- Calamine lotion can dry the skin and may need an emollient alongside it for dry or eczematous skin.
- Avoid contact with the eyes and broken skin where not appropriate.
Monitoring
Review symptomatically to confirm relief of itch and to reconsider the diagnosis if symptoms persist.
Counselling the patient
- Shake the lotion before use and dab onto the itchy area, allowing it to dry.
- It is for symptom relief only and can be reapplied as needed.
- Use a moisturiser as well if the skin becomes too dry.
Evidence & guidelines
Calamine preparations are long-established over-the-counter remedies for the symptomatic relief of pruritus and minor skin irritation.
Reference: NICE CKS Chickenpox; NICE CKS Insect bites; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD